Matthias Jackwerth
Vienna, 1090, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
In vivo evidence of functional OATP2B1 activity in human skeletal muscle using [11C]erlotinib PET.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: October 08, 2025
Endovascular thrombectomy with or without intravenous thrombolysis in large-vessel ischemic stroke: an updated meta-analysis.
Journal: Scientific reports
Published: August 27, 2025
Imaging P-glycoprotein function at the blood-brain barrier in drug-resistant epilepsy using [11C]metoclopramide.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 27, 2025
Functional MRP1 activity in human skeletal muscle.
Journal: British journal of pharmacology
Published: March 20, 2025
Immunogenicity, safety, and reactogenicity of concomitant administration of the novavax vaccine against Omicron XBB.1.5 (NVX-CoV2601) and a 20-valent pneumococcal conjugate vaccine in adults aged ≥60 years: A randomised, double-blind, placebo-controlled, non-inferiority trial.
Journal: The Journal of infection
Published: September 25, 2024
Effect of probenecid on the whole-body disposition of 6-bromo-7-[11C]methylpurine in humans assessed with long axial field-of-view PET/CT.
Journal: European journal of nuclear medicine and molecular imaging
Published: September 19, 2024
[11C]Metoclopramide PET can detect a seizure-induced up-regulation of cerebral P-glycoprotein in epilepsy patients.
Journal: Fluids and barriers of the CNS
Published: August 19, 2024
First-in-human evaluation of 6-bromo-7-[11C]methylpurine, a PET tracer for assessing the function of multidrug resistance-associated proteins in different tissues.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 22, 2024
Advancing 6-bromo-7-[11C]methylpurine to clinical use: improved regioselective radiosynthesis, non-clinical toxicity data and human dosimetry estimates.
Journal: EJNMMI radiopharmacy and chemistry
Published: March 14, 2024
St. John's wort extract with a high hyperforin content does not induce P-glycoprotein activity at the human blood-brain barrier.
Journal: Clinical and translational science
Published: February 22, 2024
Showing 1-11 of 11
Last Updated: 09/26/2026